Actively Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease
Led by Beijing Tongren Hospital · Updated on 2024-09-19
128
Participants Needed
2
Research Sites
172 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Objective: To evaluate the effect of transcutaneous auricular vagus nerve stimulation (taVNS) for the patients with dry eye disease with meibomian gland dysfunction. Methods: We enrolled 256 patients at Beijing Tongren Hospital. Patients completed questionnaires at baseline, 1 month, 3 months, and 6 months.OSDI score, TBUT, Schirmer I, tCFS, MGD score, and psychological status to evaluate the therapeutic effects. A difference of P \< 0.05 was considered statistically significant.
CONDITIONS
Official Title
Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 75 years
- Clinical diagnosis of dry eye disease
You will not qualify if you...
- History of depression, tumors, thyroid disease, diabetes, or cardiac diseases
- History of ophthalmology surgery
- Pregnant or lactating women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Beijing Tongren Hospital
Beijing, China
Actively Recruiting
2
Wu Dong
Beijing, China
Completed
Research Team
D
Dong Wu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here